In summary, we demonstrated that S1R could act as a pro-angiogenic agent via activation of JAK2/STAT3 pathway on endothelial cells, followed by augmented myocardial perfusion to improve cardiac function and ventricular remodeling after MI. The gene discussed is STAT3; the disease is myocardial infarction.